The aim of this study was to investigate the effect of fasting and exogenous insulin administration on the expression of growth hormone receptor (GHR) and IGF-I mRNA in the pre-ovulatory follicle of ewes. Fifteen ewes received an intravaginal progesterone releasing device that was removed 6 days later (day of removal 5 day 0). On day 22, the ewes were divided into three groups: (i) fasting group (n 5 5) that was fasted from day 22 to day 2; (ii) control group (n 5 5) that received a maintenance diet; and (iii) insulin group (n 5 5) that received insulin injections (0.25 IU/kg) every 12 h from day 22 to day 2 under the same diet as the control group. Follicular samples were obtained on day 2. Fasting increased plasma non-esterified fatty acids concentrations from day 21 to day 2 (P , 0.001). There was no difference ( P . 0.05) in the number of follicles, although there was a tendency for an increase in the pre-ovulatory follicle diameter for the insulin group in comparison to the control group ( P 5 0.12). Thecal GHR mRNA expression was very low and was considered insignificant. Moreover, granulosa cells GHR mRNA expression increased ( P , 0.05) in the insulin group. Expression of IGF-I mRNA was not different among groups in both tissues. In conclusion, insulin administration increases GHR mRNA but not IGF-I mRNA expression in granulosa cells of the pre-ovulatory follicle. However, fasting did not change the pattern of GHR/IGF-I mRNA expression in the pre-ovulatory follicle.
RESUMO -Objetivou-se verificar a redução de perdas embrionárias por meio do bloqueio da secreção de prostaglandina com a utilização de flunixin meglumine (FM) e avaliar o retorno econômico desta técnica. No experimento 1, utilizaram-se vacas de corte no pós-parto e, no experimento 2, somente novilhas. Todas as fêmeas foram sincronizadas e inseminadas em tempo fixo (IATF) e, após 14 dias da IATF, foram distribuídas em dois grupos: grupo flunixin meglumine (GFM), composto de 59 vacas no experimento 1 e 23 novilhas no experimento 2; e grupo controle (GC), de 56 vacas no experimento 2 e 20 novilhas no experimento 1, que receberam ou não flunixin no dia 14, respectivamente. O tratamento com flunixin não influenciou a taxa de prenhez, que, no experimento 1, foi de 42,4% no grupo flunixin e 42,8% no grupo controle e, no experimento 2, de 39,1% no grupo flunixin e 25,0% no grupo controle. Verificou-se rentabilidade de 21,62; 9,24; 14,36 e 12,06% para os protocolos dos grupos controle e flunixin dos experimentos 1 e 2, respectivamente. A taxa de prenhez não foi influenciada pelo uso de flunixin meglumine no dia 14 após inseminação artificial em vacas no pós-parto e novilhas inseminadas em tempo fixo. Palavras-chave: antiinflamatório não-esteróide, bovinos de corte, mortalidade embrionária Biological and economic evaluation of flunixin meglumine in postpartum beef cows and heifers inseminated at fixed timeABSTRACT -This study aimed to evaluate the effectiveness and the economical advantage of using flunixin meglumine (FM) to block uterine secretion of prostaglandin in order to reduce embryonic losses in beef cattle females. Postpartum cows (E1) and heifers (E2) were submitted to estrus synchronization and inseminated at fixed time. Fourteen days after the insemination the animals were assigned to the FM treatment group (FMG, including 59 cows and 23 heifers) and to the control group (CG, including 56 cows and 20 heifers). Pregnancy rates (42.4% for FMG and 42.8% for CG in E1) and (39.1% for FMG and 25.0% for CG in E2) did not differ between groups. Estimates of net income were 21.62, 9.24, 14.36 and 12.06% for the CG e FMG protocols in cows and in heifers, respectively. The use of FM at 14 days after AI did not affect pregnancy rates of postpartum beef cows and heifers.
Background:In livestock animals, which artificial insemination (AI) is widely spread, a healthy uterine environment is an important factor that should be taken into account for an adequate fertilization and establishment and development of pregnancy. The main limitation to spread the frozen semen insemination in sheep is the high costs of the laparoscopy AI and the difficulty of traversing the cervix. To overcome problems associated with transcervical artificial insemination, new techniques and instruments have been proposed. The manipulation of cervix during transcervical artificial insemination in sheep can lead to a local inflammatory reaction that releases inflammatory mediators, such as prostaglandins and cytokines, that either can negatively affect the uterine environment and consequently, the conception. In this regard, the injection of a non-steroidal anti-inflammatory (NSAI) at the moment of AI could reduce the secretion of inflammatory mediators, promoting a healthier uterine environment favorable to conception. The flunixin meglumine is a NSAI which reduces the synthesis of PGF 2 á by the inibition of the cyclooxigenase. The objective of this study was to evaluate the effect of flunixin meglumine (non-steroid antiinflammatory) injection on pregnancy rate of ewes inseminated by the transcervical technique. Materials, Methods & Results:In this experiment 69 pluriparous ewes were used, 29 in control group (CG) and 40 in flunixin meglumine group (FMG). The estrus detection was performed twice daily for 5 days. The ewes detected with paint in the low back were considered in estrus. The AI procedure was performed 8 hours after the estrus detection. At the AI time, the ewes were separated according to body condition score in two experimental groups. The ewes of the FM Group were injected with 1.1 mg/Kg of flunixin meglumine, im, 1 hour before the AI procedure. In order to locate the ostium, a vaginal speculum and a source of external light were used; whereas the fixation and traction of the ostium were performed with an Allis clamp, allowing the penetration of the semen applicator throw the vagina and cervix. The insemination procedure was performed 8 hours after estrous detection. There was no difference (P > 0.05) on the pregnancy rate between groups, whereas the Control group had 68.9% and the FM group had 60.0% of pregnancy.Discussion: The result demonstrates that the local inflammatory reaction caused by the traction of cervix was not detrimental to uterine environment and fertilization, since a high pregnancy rate was detected in both groups. Although the hypothesis of this study was not supported by the results, the high pregnancy rate detected in this experiment was higher than the results normally detected. Several studies have shown low pregnancy rates when transcervical artificial insemination with frozen semen is used associated to protocols of estrous synchronization. The flunixin meglumine did not improve the pregnancy rate, probably due to the insemination procedure adopted, since the traction ...
414 bactérias, provocando alterações no crescimento e na atividade metabólica dos microrganismos ru-Efeito da adição de glucomanano modificado em dietas contendo aflatoxina sobre parâmetros clínicos de ovinos Effect of the modified glucomannan in diets containing aflatoxin on the clinical parameters in sheep Resumo O objetivo deste estudo foi determinar o efeito do adsorvente (ADS) glucomanano modificado sobre parâmetros clínicos, hematológicos e ruminais de ovinos submetidos a dietas contendo aflatoxina (AFLA). Foram utilizadas 22 ovelhas mestiças (Corriedale e Texel), com 18 meses de idade. Os animais foram divididos em quatro grupos, de acordo com a adição de AFLA (1,5 PPM) ou ADS (2 PPM) na fração concentrada da dieta: animais recebendo AFLA na dieta (AFLA; n=6); animais recebendo AFLA e ADS na dieta (AFLA/ADS; n=6); animais recebendo ADS na dieta (ADS; n=5) e grupo controle, sem adição de ADS ou AFLA na dieta (CONTROLE; n=5). As dietas foram fornecidas por um período de 42 dias. Foram realizadas coletas de fluido ruminal a cada sete dias e avaliações clínicas (exame físico geral, urinálise e hemograma) a cada 10 dias. Quanto ao perfil leucocitário, a suplementação com adsorvente aumentou a concentração plasmática de eosinófilos. Os demais parâmetros clínicos e ruminais não foram influenciados pela presença do adsorvente ou da aflatoxina na dieta. Assim, o adsorvente glucomanano modificado influenciou a resposta leucocitária de ovinos, porém sem efeito na função ruminal e nos parâmetros clínicos avaliados. Palavras-chave: Micotoxina. Adsorvente. Leucócitos. Rúmen. Ovelha. AbstractThe aim of this study was to determine the effect of modified glucomannan adsorbent (ADS) on the clinical, hematological and ruminal parameters in sheep subjected to diets containing aflatoxins (AFLA). Twenty two crossbred ewes (Corriedale vs Texel), aging 18 months were separated into four groups according to the addition of AFLA (1,5 PPM) or ADS (2 PPM) in the concentrate portion of the diet: animals receiving AFLA in the diet (AFLA; n=6); animals receiving AFLA and ADS in the diet (AFLA/ADS; n=6); animals receiving ADS in the diet (n=5) and control group, without addition of the ADS or AFLA in the diet (CONTROL; n=5). The diets were supplied during 42 days. Ruminal fluid was collected and analysed every seven days and the clinical evaluations (clinical examination, urinalysis, and hemogram) every 10 days. The addition of adsorbent increased the plasmatic concentration of eosinophiles. Clinical and ruminal parameters were not affected by the presence of adsorbent or aflatoxin into the diet. The modified glucomannan adsorbent influenced the leukocyte response of sheep, but no effect on ruminal function and clinical parameters.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.